Citius Pharmaceuticals Inc (CTXR)
0.3284
-0.06
(-14.86%)
USD |
NASDAQ |
Nov 14, 16:00
0.3451
+0.02
(+5.09%)
After-Hours: 20:00
Citius Pharmaceuticals Free Cash Flow (Quarterly): -8.367M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -8.367M |
| March 31, 2024 | -7.786M |
| December 31, 2023 | -6.135M |
| September 30, 2023 | -6.800M |
| June 30, 2023 | -9.583M |
| March 31, 2023 | -7.853M |
| December 31, 2022 | -4.824M |
| September 30, 2022 | -6.332M |
| June 30, 2022 | -7.712M |
| March 31, 2022 | -9.665M |
| December 31, 2021 | -4.652M |
| September 30, 2021 | -45.59M |
| June 30, 2021 | -4.830M |
| March 31, 2021 | -4.271M |
| December 31, 2020 | -9.565M |
| September 30, 2020 | -3.358M |
| June 30, 2020 | -3.993M |
| March 31, 2020 | -4.468M |
| December 31, 2019 | -5.114M |
| September 30, 2019 | -2.907M |
| June 30, 2019 | -3.522M |
| March 31, 2019 | -3.850M |
| December 31, 2018 | -2.158M |
| September 30, 2018 | -2.505M |
| June 30, 2018 | -2.246M |
| Date | Value |
|---|---|
| March 31, 2018 | -4.126M |
| December 31, 2017 | -2.441M |
| September 30, 2017 | -3.429M |
| June 30, 2017 | -2.402M |
| March 31, 2017 | -0.8246M |
| December 31, 2016 | -1.315M |
| September 30, 2016 | -1.767M |
| June 30, 2016 | -2.562M |
| March 31, 2016 | -0.8745M |
| December 31, 2015 | -0.6971M |
| September 30, 2015 | -0.7053M |
| June 30, 2015 | -0.6284M |
| March 31, 2015 | -0.3169M |
| December 31, 2014 | -0.7348M |
| June 30, 2014 | -0.0485M |
| March 31, 2014 | -0.0325M |
| December 31, 2013 | -0.5219M |
| September 30, 2013 | -0.0074M |
| June 30, 2013 | -0.0032M |
| March 31, 2013 | -0.0097M |
| December 31, 2012 | -0.0002M |
| September 30, 2012 | -0.0054M |
| June 30, 2012 | -0.006M |
| March 31, 2012 | -0.0067M |
| December 31, 2011 | -0.0022M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-45.59M
Minimum
Sep 2021
-3.358M
Maximum
Sep 2020
-8.468M
Average
-6.332M
Median
Sep 2022
Free Cash Flow (Quarterly) Benchmarks
| Agilent Technologies Inc | 360.00M |
| Seelos Therapeutics Inc | -0.972M |
| Cara Therapeutics Inc | -12.65M |
| Moleculin Biotech Inc | -6.113M |
| Citius Oncology Inc | -- |